US · Healthcare

Tenaya Therapeutics Inc (TNYA)

Biotechnology

Tenaya Therapeutics Inc (TNYA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for TNYA

P/E ratio

25.00

Tenaya Therapeutics Inc (TNYA) — FAQ

What is TNYA's P/E ratio?

The price-to-earnings (P/E) ratio for Tenaya Therapeutics Inc (TNYA) is 25.00 (data as of 2026-05-23).

Does Tenaya Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Tenaya Therapeutics Inc (TNYA). Check the MyAverix Finance app for the latest dividend data.

What sector is Tenaya Therapeutics Inc in?

Tenaya Therapeutics Inc (TNYA) is classified in the Healthcare sector (Biotechnology industry).

What exchange is TNYA listed on?

TNYA is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)